Johnson & Johnson is using AI to accelerate drug discovery efforts, saying the technology has cut the time needed to generate early-stage drug development leads by half. The company revealed that AI drug discovery tools are helping researchers...
Akums Drugs & Pharmaceuticals Limited has announced the launch of Aztreonam-Avibactam Injection, a new antibiotic therapy designed to tackle multidrug-resistant gram-negative bacterial infections. The move comes at a time when rising...
Apollo Athenaa has launched an integrated robotic gynae-oncology ecosystem to improve treatment and care for women diagnosed with reproductive cancers. The initiative aims to address gaps in women’s cancer care by bringing together diagnosi...
The European Commission has approved Novartis Rhapsido (remibrutinib treatment) for adults suffering from chronic spontaneous urticaria (CSU treatment) who do not respond well to antihistamines. The European Commission approval gives patien...
India’s medical technology industry has welcomed the India–New Zealand Free Trade Agreement (FTA), calling it a positive step toward boosting trade and expanding export opportunities. However, industry leaders say a key regulatory gap remai...
Max Healthcare Institute Ltd has joined a global dengue research initiative under the Indo-European COMBAT initiative to advance dengue science and pandemic readiness. The Max Healthcare dengue research initiative is supported by the Department...
Cohance Lifesciences has appointed Umang Vohra as its new Executive Chairman and Group CEO, marking a major leadership shift aimed at driving growth. The company said Umang Vohra will take charge as Executive Chairman from May 1, 2026...
Zydus Lifesciences Limited has received approval to begin Phase III clinical trials of Zintrodiazine for treating malaria in India, marking a key step in its push to develop new therapies against the disease. The company said the Zintrodiazine...
India’s pharma sector funding, investment, mergers, and acquisitions activity during April 20–26 highlights a week shaped by mega M&A deals, strategic investments, and capital allocation moves. From Sun Pharma’s global acquisition to AI-driven...
The Union Health Ministry has clarified that there has been no change in the treatment plan for Tuberculosis treatment in India, countering misleading claims circulating on social media. Recent online posts suggested that the country had adopt...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")